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In intact sheep gonadotropes. the protem kinase mhibltor. staurosporme, mhlblted the stlmulatory effect of phorbol I?-mynstate 13-acetate (PMA) 
on lutemlzing hormone (LH) secretlon. Under the same condltlons staurosporme enhanced gonadotrophu-releasing hormone (GnRH)-stimulated 
LH exocytosis wlthout altering the EC,, of GnRH and without affecting basal LH exocytosls These results suggest that PKC does not play a 
major role m medlatmg acute GnRH-stimulated LH exocytosls. Furthermore. they demonstrate that staurosponne enhances GnRH stimulus- 
secretlon couphng. Both extracellular Ca”+-dependent and Ca” -Independent components of GnRH-stimulated LH secretlon were enhanced by 
the drug Staurosporme had no effect on GnRH stlmulatlon of CAMP and mosltol phosphate synthesis. In permeablhzed cells staurosporme chd 
not enhance Ca*‘- and CAMP-stimulated LH exocytosls. Based on these results we hypothesize that staurosponne mhlblts a protein klnase which 
IS activated by GnRH and which negatively modulates GnRH stimulus-secretion couphng 
Lutemlzing hormone: Gonadotropu-releasmg hormone: Staurosponne: Protem kmase C, Gonadotrope 
1. INTRODUCTION 
The binding of gonadotropin-releasing hormone 
(GnRH) to specific receptors on the surface of 
gonadotropes is followed rapidly by an increase in 
cytosolic [Ca2+]rree and the secretion of luteinizing hor- 
mone (LH) (for review see [l]). Ca’+ is thought to be 
the major intracellular second messenger coupling 
GnRH binding to LH secretion [l]. GnRH also causes 
(i) rapid translocation of protein kinase C (PKC) from 
the cytosol to membrane [2,3], and (ii) phosphorylation 
of cellular proteins which is inhibited by PKC depletion 
or a PKC inhibitor [4]. Although these results indicate 
that GnRH causes activation of PKC, studies using 
gonadotropes depleted of PKC to investigate whether it 
mediates GnRH-stimulated LH release have produced 
conflicting results [5-71. 
We have used staurosporine, a recently isolated 
microbial alkaloid [8], to investigate a role for PKC in 
acute GnRH-stimulated LH secretion. Staurosporine is 
the most potent PKC inhibitor known though it also in- 
hibits other protein kinases [8,9]. We report here that 
staurosporine enhances GnRH-stimulated LH ex- 
ocytosis which argues against a role for PKC and sug- 
gests that a protein kinase other than PKC may 
negatively modulate GnRH stimulus-secretion 
coupling. 
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2. EXPERIMENTAL 
Staurosponne, obtained from Boehringer-Mannheim (Mannheim, 
FRG), was dissolved m dimethylsulphoxide at 1 mM (w/v) and 
stored at 4°C. Myo-[2-ZH]inositol was from Amersham Interna- 
tional. Ovine LH (NIADDK-oLH-I-3) and ovine LH antiserum 
(NIADDK-anti-oLH-1) were kindly provided by the NIDDK. 
Staphylococcus aureus a-to‘rm was obtained from Dr Sucharit 
Bhakdl (Institute of Medical MicrobIology, Justus Llebig University, 
Giessen, FRG) Other chemicals were obtained from Sigma Chemical 
Cso. (St. Louis, MO, USA). 
Primary sheep anterior pituitary cell cultures were dispersed and 
cultured for 48 h in 12.well tissue culture plates as described [lo]. In 
intact cell experiments cells were washed 3-4 times in physiological 
buffer (buffer I in [lo]) and then stimulated in buffer I (containing 
added agents) for 20 min after which the medium was removed for 
LH determination by radiolmmunoassay [lo]. 
Permeabilized cell experiments were performed as described 
previously [lo]. Briefly, the cells were washed twice with buffer I and 
then once in Ca’+-free buffer I before being permeabilized by incuba- 
tion for 20 min at 37°C in intracellular buffer (buffer IC, described 
in [lo]) containing 3 pg/ml a-toxin and 0.5 mM EGTA. Following 
permeabilization, the cell culture plates were cooled on ice for 10 mm 
before equilibration with Ice-cold stimulation buffer for 30 min. 
Stimulation buffer comprised buffer IC with 10 mM Ca-EGTA buf- 
fer @Ca = 7, prepared as described [lo]). LH exocytosis was initiated 
by replacing the stimulation buffer with identical buffer at 37°C. 
Total cellular LH was measured after solubilizing the cells in Nonidet 
NP40 (l%, v/v) and LH released is expressed as a percentage of the 
total cellular LH. 
Total inositol phosphate productlon was measured as described 
[l 11. Briefly, cells were labelled with myo-[2-3H]inositol overmght, 
washed as above, stimulated in the presence of LiCl (10 mM) for 
40 min, and inositol phosphates were chromatographed on Dowew 
columns. For CAMP measurements, cells cultured in 6-well plates (3 
pltuitanes/plate) were washed and stimulated in buffer I which was 
removed after 60 min and replaced with 0.1 M HCI for extraction of 
cellular CAMP. The extract was neutralized with 100 mM Tris before 
CAMP determination by RIA (Amersham kit no. TKR 342). 
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Table 1 
Effects of staurosporine on GnRH-stimulated rnositol phosphate 
production 
Total inositol phosphates” 
(% of control) 
Control 
Staurosporme 100 nhl 
GnRH IO-” Xl 
GnRH plus staurosporme 
’ hlean and SE of 3 expertments 
100 
101 i 2s 
264 k 43 
231 * 39b 
’ Not significantly different from GnRH alone 
Cells prelabelled wtth myo-[2-‘Hlmositol ovrrmght were washed and 
then strmulated for 40 mm in the presence of 10 mM LiCI. Cells were 
preincubatsd for 30 mm wtth staurosporine or vehicle before 
sttmulation 
Table II 
Effect of ctaurosporine on GnRH-stimulated cAMP productron 
% LH released” Cellular cAMP” 
(pmol/well) 
Control 9.2 !I 0.5 7.2 k 0.4 
Staurosporrne 100 nM 7.0 + 0 3 8.8 + 0.6 
GnRH IO-” M 12.5 + 0.2 13.6 + 0 8 
GnRH plus staurosporine 16.0 i 0.8” 13.9 t 0.1’ 
* Mean and SE of triphcate determmations 
b Sigmficantly drfferent from GnRH alone (P < 0.01) 
’ Not sigmficantly dtfferent from GnRH alone 
Cells were premcubated for 30 mm with staurosporine and then 
stimulated for 60 mtn in the presence of 0.25 mhl 
3.isobutyl-1-methylxanthine. After stimulation medium was remoced 
for LH determinatton and the cells were processed for cAhlP 
determination 
All data are representative of results from experrments performed 
at least 3 trmes except m Table I whtch combtnes data from 3 ex- 
periments. Data points and error bars represent the mean and range 
of duphcate determinattons (Figs l-3) or the mean and SE of 
trtphcate (Tables I and II) determmatrons. Statrstrcal sigmfrcance was 
tested, where rndtcated. usmg the Student’s t-teat. 
3. RESULTS AND DISCUSSION 
In primary cultures of sheep anterior pituitary cells, 
staurosporine enhanced GnRH-stimulated LH secre- 
tion (EC50 = 30 nM) as shown in Fig. lA, a typical ex- 
periment. In 8 independent experiments, staurosporine 
enhanced LH release stimulated by IO-” M GnRH by 
104 f 17% (mean f SD) without affecting basal 
release. In contrast, staurosporine (IC50 = 10 nM) an- 
tagonized the stimulatory effect of phorbol 
12-myristate 13-acetate (PMA) on LH secretion in- 
dicating that the drug is an effective inhibitor of PKC 
in gonadotropes (Fig. 1A). This finding argues against 
a significant stimulatory role for PKC in acute GnRH- 
stimulated LH secretion. Although the stimulatory ef- 
fect of staurosporine might suggest an inhibitory role 
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Frg I Effects of staurosportne on phorbol-ester- and GnRH- 
strmutated LH release (A) After prerncubation for 30 min with the 
Indicated concentration of stauroaporme. cells were stunulated for 
20 min in the presence of the same staurosportne concentrattons wtth 
no addition (t ), PMA 100 r&l (A), or GnRH 10mh M (0). (B) After 
preincubation m the presence (0) or absence ( ) of staurosporine 
(100 nM). cells were stimulated for 20 min wrth the tndrcated 
concentratton of CnRH with (0) or wthtout (, ,) stauroaporine. 
for PKC in GnRH-stimulated LH secretion this seems 
unlikely since PKC-activating phorbol esters enhance 
both basal and GnRH-stimulated LH exocytosis 
[1,12,13]. 
Staurosporine had no effect on LH secretion in the 
absence of GnRH (Fig. 1A) and enhanced secretion at 
maximal GnRH concentrations without affecting the 
EC50 of GnRH (Fig. 1B). These findings suggest that 
the drug acts by enhancing GnRH stimulus-secretion 
coupling and not by stimulating secretion directly or by 
altering the affinity of the GnRH receptors. This could 
involve (i) enhancing the GnRH-stimulated generation 
of second messengers such as Cal+ and CAMP or (ii) in- 
creasing the sensitivity of the secretory apparatus to the 
generated second messengers. 
-7 - 
Fig. 2. Effects of staurosporrne on GnRH-strmulated LH release at 
carytng eztracellular [Ca”]. Cells were preincubated wtth (0, A) or 
without ( , A) staurosporine firstly for 25 mm m buffer 1 and then 
for 5 mm m Ca’+-free buffer I before stimulation for 20 mm in the 
presence of the indicated amounts of extracellular Ca” or EGTA 
with the followmg additions: (A) none; (A) staurosporme 100 nhl; 
( J) GnRH lOmh M; (0) staurosporine plus GnRH. ‘Ca free’ refers to 
no added Ca’- 
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Fig. 3. Effects of staurosporine on CAMP-stimulated LH release. 
Permeabihzed cells were equilibrated at 0°C for 30 min in 
stimulation buffer @Ca = 7) with staurosporine (0) or vehicle 
MelSO (13) (0.01% v/v) and the mdicated cAMP concentrations. 
Staurosporine was added after 5 min of permeabilizatton and was 
present throughout. LH exocytosis was inittated by addttion of 
stimulation buffer at 37°C and LH released after 20 mm was 
measured. 
GnRH is known to increase the cytosolic [Ca2+]f,,, 
by (i) stimulating entry of extracellular Ca” through 
plasma membrane Ca2+ channels [ 14,151 and (ii) 
stimulating the release of intracellular stored Ca2+, 
most likely through activation of the inositol 
phospholipid signalling system [1,16]. Since 
staurosporine enhanced GnRH-stimulated LH release 
even in the absence of extracellular Ca2+, it appears 
unlikely that it acts by enhancing Ca2+ entry (Fig. 2). 
PKC has been shown to negatively modulate the in- 
ositol phospholipid signalling system in many cell types 
[ 17,181. We therefore examined whether staurosporine 
had a stimulatory effect on GnRH-stimulated inositol 
phosphate generation, and found none (Table I). These 
data do not exclude the possibility that staurosporine 
might inhibit a cytosolic [Ca’+]r,,,-lowering mechanism 
activated by GnRH, by analogy with other ligands 
which operate via Ca2’-mobilization ]191. 
Staurosporine also did not enhance GnRH-stimulated 
CAMP production under conditions where it enhanced 
GnRH-stimulated LH secretion (Table II). 
cu-Toxin-permeabilized cells were used to examine 
whether staurosporine enhanced the sensitivity of the 
secretory apparatus to intracellular second messengers. 
We have previously demonstrated that staurosporine 
does not enhance Ca2+-stimulated LH exocytosis [20]. 
Staurosporine did not enhance CAMP-stimulated LH 
exocytosis but was inhibitory (Fig. 3), as expected from 
its known inhibitory effects on CAMP-dependent pro- 
tein kinase in vitro [8,9]. 
Although the above results have excluded several 
possible mechanisms for the enhancement of GnRH- 
stimulated LH release by staurosporine, its mode of ac- 
tion remains elusive. Since staurosporine is an inhibitor 
of several protein kinases [8,9], it is possible that the 
drug inhibits an unidentified protein kinase which is a 
negative modulator of GnRH stimulus-secretion 
coupling. 
Acknowledgements: This work was supported by grants from the 
South African Medical Research Council, the Stella and Paul 
Loewenstein Trust, the National Cancer Association, and the Univer- 
sity of Cape Town. 
REFERENCES 
111 
PI 
I31 
I41 
I51 
161 
171 
WI 
[91 
1~01 
Iill 
[I21 
[I31 
I141 
(151 
[I61 
[I71 
[I81 
[I91 
WI 
Huckle, W.R. and Corm, P.M. (1988) Endocr. Rev. 9, 
387-395. 
Hirota, K., Hirota, T., Aguilera, G. and Catt, K J. (1985) J. 
Biol. Chem. 260, 324333246. 
Naor, Z., Zer, J., Zakut, H. and Hermon, J. (1985) Proc. Natl. 
Acad. Sci. USA 82, 820338207. 
Strulovici, B., Tahilramani, R. and Nestor, J.J., Jr (1987) 
Biochemistry 26, 600556011, 
Conn, P.M. (1989) Mol. Endocrinol. 3, 755-757. 
McArdle, C.A., Huckle, W.R. and Conn, P.M. (1987) J. Biol. 
Chem. 262, 5028-5035. 
StOJllkOViC, S.S., Chang, J.P., Ngo, D. and Catt, K.J. (1988) 
J. Btol. Chem. 263, 17307717311. 
Tamaoki, T., Nomoto, H., Takahashi, I., Kato, Y., Mortmoto, 
M. and Tomita, F. (1986) Btochem Biophys. Res. Commun. 
135, 397-402. 
Ruegg, U.T. and Burgess, G.M. (1989) Trends Pharmacol. Sci. 
10, 2188220. 
Van der Merwe, P.A., Millar, R.P., Wakefield, I.K. and 
Davtdson, J.S. (1989) Biochem. J. 264, 901-908. 
Davidson, J.S., Wakefield, I.K., Sohnius, U., Van der Merwe, 
P.A. and Millar, R.P. (1990) Endocrinology 126, 80-87. 
Naor, Z., Schvartz, I., Hazum, E., Azard, A. and Hermon, J. 
(1987) Biochem. Biophys. Res. Commun. 148, 1312-1322. 
Beggs, M.J. and Miller, W.L. (1989) Endocrinology 124, 
667-674. 
Chang, J.P., McCoy, E.E., Graeter, J ., Tasaka, K. and Catt, 
K.J. (1986) J. Biol. Chem. 261, 9105-9108. 
Davidson, J.S., Wakefield, I.K., King, J.A., Mulhgan, G.P. 
and Millar, R.P. (1988) Mol. Endocrinol. 2, 382-390. 
Naor, Z., Capponi, A.M., Rossier, M.F., Ayalon, D. and 
Limor, R. (1988) Mol. Endocrinol. 2, 5122520. 
Berridge, M.J. (1987) Annu. Rev. Biochem. 56, 159-193. 
King, W.G. and Rittenhouse, S.E. (1989) J. Biol. Chem. 264, 
6070-6074. 
McCarthy, S.A., Hallam, T.J. and Merritt, J.E. (1989) 
Biochem. J. 264, 357-364. 
Van der Merwe, P.A., Millar, R.P. and Davidson, J.S. (1990) 
Biochem. J., in press. 
113 
